Appen Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APPEF research report →
Price Chart
About the company
Appen Limited operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally. It operates through the Appen Global and Appen China segments. The company offers CrowdGen, the interface for its global crowd workforce; Mercury, the backend system used to design projects, manage the crowd workforce, and automate operational workflows; AI Data Platform (ADAP), which enables internal teams and external customers to design, manage, and execute human annotation and evaluation tasks; MatrixGo, the core platform supporting data collection and annotation services; Elite AI, the expert crowdsourcing platform enables expert recruitment, task publishing, and campaign referral expansion for user acquisition; MediGo, a medical LLM and image annotation; RoboGo, an embodied intelligence; and Appen Task, a mobile data collection application.
- CEO
- Ryan Kolln
- IPO
- 2018
- Employees
- 1,185
- HQ
- Chatswood, NSW, AU
Get TickerSpark's AI analysis on APPEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $203.37M
- P/E
- -27.67
- Fwd P/E
- 28.53
- PEG
- -0.43
- P/S
- 0.78
- P/B
- 2.08
- EV/EBITDA
- 8.72
- Div Yield
- 0.00%
- Gross Margin
- 8.32%
- Op Margin
- -2.41%
- Net Margin
- -2.81%
- ROE
- -7.45%
- ROIC
- -5.87%
Latest fiscal year · YoY change
- Revenue
- $238.80M+1.9%
- Gross Profit
- $7.75M-96.7%
- Op Income
- $-21,779,325
- Net Income
- $-22,577,152-12.8%
- EPS
- $-0.09+2.3%
- OCF Growth
- +3679.1%
- FCF Growth
- +898.5%
- 52W High
- $1.33
- 52W Low
- $0.47
- 50D MA
- $0.78
- 200D MA
- $0.86
- Beta
- 1.78
- RSI (14)
- 47
- Avg Volume
- 991
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Appen delivered strong H1 FY'26 revenue and EBITDA growth, led by China, while Global stabilized and management reaffirmed full-year guidance.· August 26, 2026
- Group revenue rose 17.5% to $119.9 million, with underlying EBITDA before FX improving to $5.3 million from a year ago.
- Appen China was the standout: revenue increased 80.4% to $76.2 million and exited the half at an annualized run rate above $175 million.
- Appen Global revenue fell to $43.7 million, but management said traditional work has stabilized and new AI-lab work is growing, including 65% Q2 growth outside the largest client versus Q1.
- Gross margin was 36.7%, down 30 basis points, while management identified about $12 million in incremental annualized cost efficiencies in Global.
- FY'26 guidance was reaffirmed at $270 million to $300 million of group revenue and 5% to 10% underlying EBITDA before FX margin.
Revenue increased 17.5% to $119.9 million. Appen China revenue grew 80.4% to $76.2 million, while Appen Global revenue was down 26.9% to $43.7 million. Gross margin was 36.7%, down 30 basis points. Underlying EBITDA before FX was $5.3 million, up $7.5 million versus H1 FY'25, and EBITDA margin was 4.5%. Cash at 30 June was $44.7 million, or AUD 64.8 million. Management reaffirmed FY'26 guidance for group revenue of $270 million to $300 million and underlying EBITDA before FX margin of 5% to 10%.
Ryan Kolln framed Appen as a key supplier of bespoke real-world data for AI model development, emphasizing that unique data is becoming scarcer and more differentiated than compute or algorithms. He highlighted broader relationships with foundation model builders, expansion into higher-value domains like coding, finance and health care, and a growing data-set offering. His tone was confident and constructive, with repeated emphasis on sustainable growth, improving margins in China, and cost efficiencies in Global without harming delivery capability.
Justin Miles detailed the half-year financial bridge: revenue up 17.5% to $119.9 million, gross margin at 36.7%, and underlying EBITDA before FX up to $5.3 million. He said Appen Global employee expenses fell to $14.4 million from $17.7 million and other expenses to $8.1 million from $11.4 million, reflecting technology innovation and automation. He also noted $12 million of identified operational efficiencies, with 70% to be executed by the end of FY'26 and the remainder by Q1 FY'27. Cash flow used in operations was $2.7 million, cash used in investing was $1.9 million higher due to product development and new facilities in China, and finance cash outflows of $2.7 million were lease payments.
Analysts pressed management on whether EBITDA improvement was durable or driven by temporary project revenue; Ryan said the improvement reflects a sustainable cost base, China margin gains, and Global OpEx improvement. On cash runway and self-sustainability, Justin said the company has enough cash and working capital, sees no need for additional funds, and believes they are not too far off consistent free cash flow. Questions also focused on Global customer concentration, older legacy work declining, and the timing of larger project resumption; management said traditional work has stabilized, new work is broadening across more labs and domains, and there is still a normal second-half skew.
The positive case from this call is that China is scaling quickly with better profitability, while Global is showing signs of stabilization and new AI-lab work is broadening. Management also believes the $12 million cost-efficiency program will flow through over time, supporting margin and cash generation, and they reiterated confidence in reaching self-sustaining free cash flow.
The main risks discussed were the decline in Appen Global revenue as traditional work shrinks faster than new work offsets it, and the fact that H1 cash flow was still negative from operations. Management also acknowledged that visibility is not high, that some larger Global projects have not yet resumed, and that the business still depends heavily on a few large AI-lab relationships and project-based demand with second-half seasonality.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 92.8%
- Shares Outstanding
- 269.02M
- Float Shares
- 249.70M
Our APPEF coverage
Recent articles, reports, and earnings notes.
No research on APPEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate APPEF report →Appen Limited (APXYY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 27
Appen Limited (APXYY) Shareholder/Analyst Call Transcript
seekingalpha.com · May 22
Appen Limited (APXYY) Q4 2025 Earnings Call Transcript
seekingalpha.com · Feb 24
Appen Limited (APPEF) Q2 2025 Earnings Call Transcript
seekingalpha.com · Aug 28
Appen Limited (APPEF) Q4 2024 Earnings Call Transcript
seekingalpha.com · Feb 26
Appen Limited (APPEF) Q2 2024 Earnings Call Transcript
seekingalpha.com · Aug 29
Data Annotation and Labeling Market Size Surges to $3.6 Billion by 2027 - Led by Appen, Oracle and TELUS International | MarketsandMarkets™
globenewswire.com · Jun 3
Embattled AI firm Appen loses more executives, months after Alphabet cut ties
cnbc.com · May 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.